Sarah Rodriguez
Title | Assistant Professor |
---|
Institution | University of Chicago |
---|
Department | Ophthalmology and Visual Science |
---|
Address | Chicago IL 60637
|
---|
vCard | Download vCard |
---|
|
|
|
Overview Sarah Rodriguez, MD, MPH, provides comprehensive, compassionate care to children with decreased vision in one or both eyes. Dr. Rodriguez has expertise in treating conditions caused by abnormal eye development, such as amblyopia (lazy eye), strabismus (misalignment of the eyes), pediatric cataracts, and retinopathy of prematurity (ROP). She also specializes in adjustable sutures for adult strabismus / realignment surgery.
Dr. Rodriguez is not only passionate about delivering high-quality care to her patients, but she is also actively involved in clinical research. She received the prestigious Knights Templar Eye Foundation Career-Starter Grant to study neurodevelopmental outcomes among infants screened for ROP, and she is the Principle Investigator for the University of Chicago's involvement in the Pediatric Eye Disease Investigator Group (PEDIG). Dr. Rodriguez's research has been published in a number of scientific journals, including Ophthalmology, Pediatrics, and the Journal of the American Association for Pediatric Ophthalmology and Strabismus (J AAPOS). She is currently an Editorial Board member for J AAPOS.
Having completed several medical mission trips to Ghana and Nicaragua, she also has an interest in health disparities and global health. She participated in ROP workshops in Vietnam and South Africa, and she is a committee member for a program dedicated to preventing the next anticipated wave of ROP in Sub-Saharan Africa called SIBA (Stop Infant Blindness in Africa).
Biography Northwestern Memorial / Lurie Children's Hospital, Chicago, IL | Fellowship | 06/2016 | Pediatric Ophthalmology | The Ohio State University Havener Eye Institute, Columbus, OH | Residency | 06/2015 | Ophthalmology | Scripps Mercy Hospital, San Diego, CA | Internship | 06/2012 | Transitional Year | The Ohio State University College of Medicine, Columbus, OH | MD | 06/2011 | Medicine | La Cayetana Hereredia, Lima, Peru | | 04/2011 | Tropical Medicine Course | Johns Hopkins Bloomberg School of Public Health, Baltimore, MD | MPH | 05/2010 | Public Health | University of Notre Dame, Notre Dame, IN | BA | 06/2006 | Phiosophy |
2022 | Comer Development Board Grant | 2021 | Editorial Board Member, J AAPOS | 2018 | Knights Templar Eye Foundation Career Starter Grant | 2014 | Havener Eye Institute Free Clinic Certificate of Appreciation, Ohio State Havener Eye Institute | 2014 | Travel Grant Award for ARVO, National Eye Institute | 2013 | Consultant of the Month, Ohio State Havener Eye Institute | 2012 | Mercy Style of Care Award, Scripps Mercy Hospital | 2011 | Eli G. Alcon Award for Outstanding Senior Medical Student in Ophthalmology, The Ohio State University College of Medicine | 2010 | Capstone Award for Outstanding Achievement , Johns Hopkins Bloomberg School of Public Health | 2010 | Health Economics Certificate, Johns Hopkins Bloomberg School of Public Health | 2010 | Alpha Omega Alpha, The Ohio State University, College of Medicine | 2009 | Gold Humanism and Honor Society, The Ohio State University, College of Medicine | 2007 | Excellence in Community Service Award, The Ohio State University, College of Medicine | 2006 | Summa cum laude, University of Notre Dame | 2006 | Phi Beta Kappa, University of Notre Dame |
ORNG Applications Research (Hilkert Rodriguez, Sarah)Jan 1, 2016 - Jun 30, 2017 Novartis Rainbow Study Role Description: a randomized, controlled study evaluating the efficacy and safety of ranibizumab compared with laser therapy for the treatment of infants born prematurely with retinopathy of prematurity. Role: PI |
| (Zhang, Michael)May 1, 2017 - Jun 30, 2017 Diversity Grant: Assessing Socioeconomic Status as a Risk Factor for Severe Retinopathy of Prematurity Role: Mentor for medical student, Michael Zhang |
| (Anand, Nandita)Jun 1, 2017 - Jun 1, 2018 Role Description: ISPB Research Grant: To evaluate the long term safety and efficacy of antivascular endothelial growth factor (anti-VEGF) treatment compared to laser among patients who received treatment for retinopathy of prematurity. Role: Mentor of ophthalmology resident |
| (Hilkert Rodriguez, Sarah)Aug 1, 2017 - Aug 1, 2018 Core Grant: Using a Commercial Claims Database to Evaluate Outcomes Related to Retinopathy of Prematurity. Role: PI |
| (Hilkert Rodriguez, Sarah)Jan 1, 2018 Core Grant: Using a Commercial Claims Database to Evaluate Outcomes Related to Retinopathy of Prematurity Role: PI |
| (Theophanous, Christos)Jun 1, 2018 ISPB Research Grant: Proteomics in pediatric cataracts. Role: Mentor for ophthalmology resident, Christos Theophanous |
| (Hilkert-Rodriguez, Sarah)Jun 1, 2018 - Jun 1, 2019 Knights Templar Evaluating the efficacy of a smartphone application (Baby Moves!) to detect developmental delays among a high risk population of infants screened for retinopathy of prematurity. Role: PI |
| (Hilkert-Rodriguez, Sarah)Oct 1, 2018 ROP Hot Topics Role Description: Co-organizer for international ROP meeting, raised funding from sponsors for meeting support Role: Co-organizer |
| (Elise Timtim)Jun 1, 2019 - Jun 30, 2020 ISBP ROP Outcomes using the Medicaid Claims Database Role: Mentor for medical student, Elise Timtim |
| (Elise Timtim)Jun 1, 2019 - Jun 30, 2020 AOA Carolyn L. Kuckein Student Research Fellowship ROP Outcomes using the Medicaid Claims Database Role: Mentor for medical student, Elise Timtim |
| (Hilkert Rodriguez, Sarah)Jun 25, 2019 PEDIG Role: PI for the University of Chicago |
| (Lindsay Chun)Jul 1, 2020 - Jun 30, 2021 ISPB Research Grant Evaluating endophthalmitis after pediatric cataract surgery using an insurance claims database Role: Mentor for Ophthalmology Resident |
| (Ema Avdagic)Jul 1, 2020 - Jun 30, 2021 ISPB Research Grant Systemic hypertension after intravitreal bevacizumab therapy for type 1 ROP: is there evidence for concern? Role: Mentor for Ophthalmology Resident |
| Jan 31, 2022 - Jan 30, 2023 Comer Development Board Biomineralization and Pediatric Cataracts Role: Co-PI |
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Khanna S, Rodriguez SH, Blair MA, Wroblewski K, Shapiro MJ, Blair MP. Laser Prophylaxis in Patients with Stickler Syndrome. Ophthalmol Retina. 2022 Apr; 6(4):263-267. PMID: 34774838.
-
Rodriguez SH, Blair MP, Shapiro MJ, Berrocal AM, Ells AL, Hubbard GB, Martinez-Castellanos MA, Murray TG, Wu WC. Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol. 2021 09; 41(9):2377-2378. PMID: 34193960.
-
Shaw LT, Khanna S, Chun LY, Dimitroyannis RC, Rodriguez SH, Massamba N, Hariprasad SM, Skondra D. Quantitative Optical Coherence Tomography Angiography (OCTA) Parameters in a Black Diabetic Population and Correlations with Systemic Diseases. Cells. 2021 03 04; 10(3). PMID: 33806492.
-
Prasanna P, Sriram CS, Rodriguez SH, Kohli U. Cardiovascular involvement in alpha-n-acetyl neuraminidase deficiency syndromes (sialidosis type I and II). Cardiol Young. 2021 May; 31(5):862-864. PMID: 33507140.
-
Zhang DL, Shapiro MJ, Schechet SA, Rabiah PK, Rodriguez SH, Blair MP. Macular Sequelae Following Exudative Retinal Detachment After Laser Photocoagulation for Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2020 Dec 01; 51(12):698-705. PMID: 33339051.
-
Blair MP, Rodriguez SH, Shapiro MJ. A Potential Solution to Plus Disease Variability. Ophthalmol Retina. 2020 10; 4(10):1022-1023. PMID: 33019986.
-
Zhang MH, Blair MP, Ham SA, Rodriguez SH. Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database. Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):486-493. PMID: 32955587.
-
Skondra D, Rodriguez SH, Sharma A, Gilbert J, Andrews B, Claud EC. The early gut microbiome could protect against severe retinopathy of prematurity. J AAPOS. 2020 08; 24(4):236-238. PMID: 32707176.
-
Rodriguez SH, Schechet SA, Shapiro MJ, Blair MP. Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5. PMID: 32461148.
-
Rodriguez SH, Blair MP, Shapiro MJ, Berrocal AM, Murray TG, Martinez-Castellanos MA, Hubbard GB. Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment. Pediatrics. 2020 Apr 01; 145(4). PMID: 32234794.
-
Rodriguez SH, Peyton C, Lewis K, Andrews B, Greenwald MJ, Schreiber MD, Msall ME, Blair MP. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343. PMID: 31233150.
-
Schechet SA, Rodriguez SH, Shapiro MJ, Blair MP. Reply to comment on: "Advantages of bevacizumab for aggressive posterior retinopathy of prematurity". Taiwan J Ophthalmol. 2019 Apr-Jun; 9(2):136-137. PMID: 31198676.
-
Anand N, Blair MP, Greenwald MJ, Rodriguez SH. Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6. PMID: 30797978.
-
Theophanous C, Schechet S, Rodriguez SH, Blair M. Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896. PMID: 30457649.
-
Blair M, Gonzalez JMG, Snyder L, Schechet S, Greenwald M, Shapiro M, Rodriguez SH. Bevacizumab or laser for aggressive posterior retinopathy of prematurity. Taiwan J Ophthalmol. 2018 Oct-Dec; 8(4):243-248. PMID: 30637196.
-
Blair MP, Hilkert Rodriguez S, Chan RVP, Shapiro MJ. Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226). Ophthalmology. 2018 10; 125(10):e70-e71. PMID: 30243341.
-
Tina H. Chen, Kathryn A. Colby, Sarah Hilkert Rodriguez, Mark B. Slidell, Jessica J. Kandel, Hassan A. Shah. Availability of Resources for After-Hours Surgical Management of Eye Injuries. J Acad Ophthalm. 2018; 1(10):e92-e97.
-
Hilkert SM, Parness-Yossifon R, Mets-Halgrimson R, Mets MB. Response to Galvis et al.'s "Myopia rates in a genetically isolated population". Ophthalmic Genet. 2018 04; 39(2):295. PMID: 29172911.
-
Silas MR, Hilkert SM, Reidy JJ, Farooq AV. Posterior keratoconus. Br J Ophthalmol. 2018 07; 102(7):863-867. PMID: 29122822.
-
Hilkert SM, Parness-Yossifon R, Mets-Halgrimson R, Mets MB. Ocular biometry and determinants of refractive error in a founder population of European ancestry. Ophthalmic Genet. 2018 Jan-Feb; 39(1):11-16. PMID: 28569566.
-
Hilkert SM, Farooq AV, Greenwald MJ
. Retinoblastoma: a global perspective. Curr Ophthalmol Rep. 2017; (5):119-127.
-
Hilkert SM, Koreishi AF, Pyatetsky D. Poststreptococcal syndrome presenting as posterior scleritis in a child. J AAPOS. 2017 Apr; 21(2):163-165. PMID: 28007653.
-
Hilkert SM, Cebulla CM, Jain SG, Pfeil SA, Benes SC, Robbins SL. Breaking bad news: A communication competency for ophthalmology training programs. Surv Ophthalmol. 2016 Nov - Dec; 61(6):791-798. PMID: 27134009.
-
DiVittorio KM, Leevy WM, O'Neil EJ, Johnson JR, Vakulenko S, Morris JD, Rosek KD, Serazin N, Hilkert S, Hurley S, Marquez M, Smith BD. Zinc(II) coordination complexes as membrane-active fluorescent probes and antibiotics. Chembiochem. 2008 Jan 25; 9(2):286-93. PMID: 18076009.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2008 | 1 | 2016 | 2 | 2017 | 4 | 2018 | 4 | 2019 | 3 | 2020 | 6 | 2021 | 4 |
To return to the timeline, click here.
|
Rodriguez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|